FI831431L - Bensotiazolinfoereningar - Google Patents

Bensotiazolinfoereningar

Info

Publication number
FI831431L
FI831431L FI831431A FI831431A FI831431L FI 831431 L FI831431 L FI 831431L FI 831431 A FI831431 A FI 831431A FI 831431 A FI831431 A FI 831431A FI 831431 L FI831431 L FI 831431L
Authority
FI
Finland
Prior art keywords
bensotiazolinfoereningar
Prior art date
Application number
FI831431A
Other languages
English (en)
Other versions
FI68232B (fi
FI831431A0 (fi
FI68232C (fi
Inventor
Iwao Jun-Ichi
Oya Masayuki
Iso Tadashi
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Publication of FI831431A0 publication Critical patent/FI831431A0/fi
Publication of FI831431L publication Critical patent/FI831431L/fi
Publication of FI68232B publication Critical patent/FI68232B/fi
Application granted granted Critical
Publication of FI68232C publication Critical patent/FI68232C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
    • C07D277/66—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2 with aromatic rings or ring systems directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI831431A 1981-09-12 1983-04-27 Foerfarande foer framstaellning av benzotiazolinfoereningar me farmaceutiskt verkan FI68232C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP14414881 1981-09-12
JP56144148A JPS5846079A (ja) 1981-09-12 1981-09-12 ベンゾチアゾリン環を有するエ−テル類
PCT/JP1982/000363 WO1983000865A1 (en) 1981-09-12 1982-09-10 Benzothiazoline compounds
JP8200363 1982-09-10

Publications (4)

Publication Number Publication Date
FI831431A0 FI831431A0 (fi) 1983-04-27
FI831431L true FI831431L (fi) 1983-04-27
FI68232B FI68232B (fi) 1985-04-30
FI68232C FI68232C (fi) 1985-08-12

Family

ID=15355326

Family Applications (1)

Application Number Title Priority Date Filing Date
FI831431A FI68232C (fi) 1981-09-12 1983-04-27 Foerfarande foer framstaellning av benzotiazolinfoereningar me farmaceutiskt verkan

Country Status (18)

Country Link
US (3) US4479949A (fi)
JP (1) JPS5846079A (fi)
AT (1) AT379592B (fi)
AU (1) AU541223B2 (fi)
BE (1) BE894358A (fi)
CA (1) CA1169860A (fi)
CH (1) CH654001A5 (fi)
DE (1) DE3248957T1 (fi)
DK (1) DK164403C (fi)
ES (2) ES8308552A1 (fi)
FI (1) FI68232C (fi)
FR (1) FR2512820B1 (fi)
GB (1) GB2115815B (fi)
IT (1) IT1196423B (fi)
NL (1) NL8220310A (fi)
NO (1) NO831653L (fi)
SE (1) SE444681B (fi)
WO (1) WO1983000865A1 (fi)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56164877A (en) * 1980-05-23 1981-12-18 Fujitsu Ltd Manufacture of head for thermal printer
JPS5846079A (ja) * 1981-09-12 1983-03-17 Santen Pharmaceut Co Ltd ベンゾチアゾリン環を有するエ−テル類
DK143684A (da) * 1983-03-12 1984-09-13 Bayer Ag Anvendelse af pyrazolonderivater som lipoxygenasehaemmer ved terapi af isaer ischaemi og hjerterytmeforstyrrelser
JPS60139679A (ja) * 1983-12-27 1985-07-24 Santen Pharmaceut Co Ltd ２−アリ−ルベンゾチアゾリン誘導体
JPS60207396A (ja) * 1984-03-31 1985-10-18 ロ−ム株式会社 配線基板
JPS61110568A (ja) * 1984-10-31 1986-05-28 アルカテル・エヌ・ブイ プリンタ装置
US4728651A (en) * 1985-10-24 1988-03-01 Hoechst-Roussel Pharmaceuticals Inc. Antihypertensive thieno-isoxazoles and -pyrazoles
JPS62221679A (ja) * 1986-03-19 1987-09-29 Santen Pharmaceut Co Ltd ベンゾチアゾリン誘導体
US5147881A (en) * 1990-11-14 1992-09-15 Pfizer Inc 4-(1,2-benzisoxazolyl)piperidine antipsychotic agents
US5541204A (en) * 1994-12-02 1996-07-30 Bristol-Myers Squibb Company Aryloxypropanolamine β 3 adrenergic agonists
CN100522954C (zh) 2002-03-29 2009-08-05 参天制药株式会社 含有2-苯基苯并噻唑啉衍生物的к-阿片样物质受体激动剂
JP6275517B2 (ja) * 2013-03-22 2018-02-07 あゆみ製薬株式会社 Ｉｌ−２産生抑制

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2996512A (en) * 1961-08-15 Therapeutic derivatives of aryl-
US3117124A (en) * 1957-03-20 1964-01-07 Olin Mathieson Benzothiazole, benzothiazine, and benzothiazepine compounds
FR1255312A (fr) * 1957-10-31 1961-03-10 Crookes Lab Ltd Dérivés des aryl-benzothiazoles et leur mode de préparation
GB1058822A (en) * 1963-07-30 1967-02-15 Ici Ltd 3-amino-2-hydroxypropoxy heterocyclic derivatives
GB1047927A (en) * 1964-03-09 1966-11-09 Ici Ltd Alkanolamine derivatives
BE754245A (fr) * 1969-08-01 1970-12-31 Sumitomo Chemical Co Derives d'acides phenoxy carboxyliques
US3574218A (en) * 1969-08-11 1971-04-06 Egyt Gyogyszervegyeszeti Gyar 2-aryl- or aralkyl-substituted benzazole derivatives
US3720683A (en) * 1970-09-02 1973-03-13 Squibb & Sons Inc 2-phenyl-3-acylbenzothiazolines and their oxides
JPS5371071A (en) * 1976-12-08 1978-06-24 Teijin Ltd Alpha-phenoxyacetic acid derivs.
JPS57179175A (en) * 1981-04-30 1982-11-04 Shinzo Kano Preparation of 2-benzothiazolinone derivative or salt thereof
JPS5846079A (ja) * 1981-09-12 1983-03-17 Santen Pharmaceut Co Ltd ベンゾチアゾリン環を有するエ−テル類

Also Published As

Publication number Publication date
GB2115815B (en) 1985-06-19
CH654001A5 (de) 1986-01-31
FR2512820B1 (fr) 1986-11-21
FI68232B (fi) 1985-04-30
GB2115815A (en) 1983-09-14
DK164403C (da) 1992-11-16
DE3248957T1 (de) 1983-10-20
SE444681B (sv) 1986-04-28
AU541223B2 (en) 1984-12-20
ES522386A0 (es) 1984-08-16
GB8311096D0 (en) 1983-05-25
FI831431A0 (fi) 1983-04-27
SE8302352D0 (sv) 1983-04-26
DK211283D0 (da) 1983-05-11
SE8302352L (sv) 1983-04-26
CA1169860A (en) 1984-06-26
IT8223146A0 (it) 1982-09-07
AU8902682A (en) 1983-03-28
ES8407033A1 (es) 1984-08-16
ATA904882A (de) 1985-06-15
DE3248957C2 (fi) 1989-09-21
ES515655A0 (es) 1983-09-16
WO1983000865A1 (en) 1983-03-17
ES8308552A1 (es) 1983-09-16
US4558125A (en) 1985-12-10
AT379592B (de) 1986-01-27
DK164403B (da) 1992-06-22
IT1196423B (it) 1988-11-16
DK211283A (da) 1983-05-11
FI68232C (fi) 1985-08-12
NO831653L (no) 1983-05-10
JPS5846079A (ja) 1983-03-17
US4552969A (en) 1985-11-12
BE894358A (fr) 1983-01-03
NL8220310A (nl) 1983-08-01
FR2512820A1 (fr) 1983-03-18
US4479949A (en) 1984-10-30

Similar Documents

Publication Publication Date Title
BE893795A (fr) Inhalateur-doseur
AT382116B (de) Geraeuschgedaempftes schienenrad
BE889765A (fr) Stijgerelement
AT372860B (de) Schipaar
BE893877A (fr) Mond-en tandverzorgingsmiddel
BE894481A (fr) Stromingsmeter
AT384100B (de) Drehrohrofen
BE891918A (fr) Draaibare schoorsteenkap
BE891837A (fr) Anthracycline-glycosides
AT385733B (de) Skibob
ATA183681A (de) Blockhaus
AT374656B (de) Maishaecksler
AT379276B (de) Hoergeraet
ATA243482A (de) Mauerstein
BE893857A (fr) Comptoir-vitrine
AT371306B (de) Hoergeraet
AT368631B (de) Zweibein
ATA492281A (de) Karniese
BE893123A (fr) Thienyl- et benzothienyl-t-butylamino-phenoxypropanols
AT374934B (de) Kapodaster
AR225979A1 (es) Tablestacado rompeolas
BR6100123U (pt) Lancabol
BR6101455U (pt) Adejonave
ATA157781A (de) Steher
BR6100124U (pt) Dedobol

Legal Events

Date Code Title Description
MM Patent lapsed
MM Patent lapsed

Owner name: SANTEN PHARMACEUTICAL CO., LTD